Business ❯ Pharmaceutical Industry ❯ Pricing Strategies

Market Dynamics

Eli Lilly Novo Nordisk Cost Analysis NHS Impact Consumer Access Regulatory Environment Competition Levels Supply Chain Issues

Lilly Cuts Zepbound Cash Prices on LillyDirect as GLP‑1 Price Competition Deepens

The direct-to-consumer price drop reflects a White House pricing framework that pushes GLP‑1 sales to company portals.

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves